Heart transplantation (HTx) has been associated to significant improvements in survival and quality of life in patients with advanced heart failure (HF). Despite a considerable increase in the indication of left ventricular assistant devices, HTx still remains the gold-standard approach in this clinical context. Even though it is considered the gold-standard treatment for advanced HF, several reasons have impaired the widespread utilization of the HTx. There is limited availability of donors compared with the growing potential recipients. Moreover, the longer […]